Advertisement

Topics

Véto-pharma S.A. Company Profile

18:16 EDT 27th June 2016 | BioPortfolio


News Articles [1214 Associated News Articles listed on BioPortfolio]

BRIEF-UK's CMA says not to refer Leo Pharma deal to buy Astellas Pharma portfolio to investigation

* Decided not to refer anticipated acquisition by Leo Pharma of the portfolio of pharma dermatological products of Astellas Pharma to phase 2 investigation Source text for Eikon: Further company cover...

Kiadis Pharma Appoints PCT as its Contract Manufacturing Organization in the United States

~ PCT will supply study medication for the US part of Kiadis Pharma's Phase III clinical trial with ATIR101™ ~ Regulatory News: Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amst.....

Moberg Pharma Divests Three Brands for $10.0 Million

Regulatory News: Moberg Pharma (STO:MOB) Moberg Pharma AB (OMX: MOB) announces that the company has entered into an agreement with Strides Pharma Inc. to divest the brands Jointflex, Fergon and Va...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

IRW-News: Veritas Pharma Inc.: Veritas Pharma Inc.: Privatplatzierungsangebot

IRW-PRESS: Veritas Pharma Inc.: Veritas Pharma Inc.: Privatplatzierungsangebot PRIVATPLATZIERUNGSANGEBOT Vancouver (British Columbia), 8. März 2016. Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; Fran...

Kiadis Pharma and the Leukemia & Lymphoma Society Enter Partnership for the Development of ATIR101™ in ALL and AML Patients

LLS will fund the Phase II development via an equity investment in Kiadis Pharma Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biop...

‘Transformative’ Alliance pharma deal supported by Lloyds Bank

Alliance Pharma has completed the £127.5m acquisition of a portfolio of dermatological assets from Sinclair IS Pharma

Targeting pharma

Ebb & Flow Targeting pharma Second Genome Inc. was looking for more than money in the $42.6 million series B round announced last week. The microbiome company also wanted to tap into pharma expertise ...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [25 Associated PubMed Articles listed on BioPortfolio]

Digital health revolution: Perfect storm or perfect opportunity for pharmaceutical R&D?

The convergence of technology and medicine has pushed healthcare to the brink of a major disruption that pharma has, until recently, been slow to recognize. Tech players have pioneered the emerging fi...

Pharma Success in Product Development-Does Biotechnology Change the Paradigm in Product Development and Attrition.

The biotechnology segment of the overall biopharma industry has existed for only about 40-45 years, as a driver of new product development. This driving force was initiated with the FDA approval of r...

Management of osteoarthritis (OA) with the pharma-standard supplement FlexiQule (Boswellia): a 12-week registry.

This registry study assessed the pharma-standard supplement FlexiQule (Boswellia extract in capsules) in the management of symptoms associated to osteoarthritis (OA) also managed with the 'standard ma...

Pharma Exposure Occurs Early in Training and More Often in Rural Clinical Sites.

Starting up and spinning out: The changing nature of partnerships between pharma and academia.

Clinical Trials [59 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [692 Associated Companies listed on BioPortfolio]

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...

Flex Pharma, Inc.

Flex Pharma, Inc. is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders. Flex Pharma has demonstrated initial human effi...

More Information about "Véto-pharma S.A." on BioPortfolio

We have published hundreds of Véto-pharma S.A. news stories on BioPortfolio along with dozens of Véto-pharma S.A. Clinical Trials and PubMed Articles about Véto-pharma S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Véto-pharma S.A. Companies in our database. You can also find out about relevant Véto-pharma S.A. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record